362
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor: Original Scientific Contributions

Adverse events associated with weight-based, high-dose montelukast exposures in childrenFootnote*

ORCID Icon, , , , &
Pages 145-146 | Received 26 Mar 2019, Accepted 12 Apr 2019, Published online: 06 May 2019

References

  • Sebaldt RJ, Sheller JR, Oates JA, et al. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. PNAS. 1990;87:6974–6978.
  • Arnold DH. Acute asthma exacerbations, viral respiratory infections, and corticosteroid treatment. Lancet Respir Med. 2016;4:930–932.
  • Camargo CA, Jr., Smithline HA, Malice MP, et al. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med. 2003;167:528–533.
  • Knorr B, Holland S, Rogers JD, et al. Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections. J Allergy Clin Immunol. 2000;106:S171–S178.
  • Arnold DH, Bowman N, Reiss TF, et al. Adverse events are rare after single-dose montelukast exposures in children. Clin Toxicol (Philadelphia, Pa). 2018;56:25–29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.